Mereo BioPharma Group plc

SEC 4 · Filed

0001193125-26-033751Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Scots-Knight Denise

Security
Share Options (Right to buy)
Code
A
Shares
480,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "0.44",
  "expiration": "2036-02-01",
  "footnotes": {
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.",
    "F3": "Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date."
  },
  "owners": [
    {
      "cik": "0001297000",
      "name": "Scots-Knight Denise",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "480000",
  "price": "0.00",
  "row": 3,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "480000",
  "table": "II",
  "underlying_security": "American Depository Shares",
  "underlying_shares": "480000"
}
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Scots-Knight Denise

Security
Share Options (Right to buy)
Code
A
Shares
345,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "1.00",
  "expiration": "2036-02-01",
  "footnotes": {
    "F1": "25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.",
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."
  },
  "owners": [
    {
      "cik": "0001297000",
      "name": "Scots-Knight Denise",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "345000",
  "price": "0.00",
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "345000",
  "table": "II",
  "underlying_security": "American Depository Shares",
  "underlying_shares": "345000"
}
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Scots-Knight Denise

Security
Share Options (Right to buy)
Code
A
Shares
1,035,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "0.44",
  "expiration": "2036-02-01",
  "footnotes": {
    "F1": "25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.",
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."
  },
  "owners": [
    {
      "cik": "0001297000",
      "name": "Scots-Knight Denise",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "1035000",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "1035000",
  "table": "II",
  "underlying_security": "American Depositary Shares",
  "underlying_shares": "1035000"
}